posttransplant lymphoproliferative disease

posttransplant lymphoproliferative disease

a complication of organ transplantation in children; characterized by a mononucleosislike syndrome, tonsillar enlargement, and Epstein-Barr virus seroconversion.

post·trans·plant lym·pho·pro·lif·er·a·tive dis·ease

(pōst-trans'plant limf'ō-prō-lif'ĕr-ă-tiv di-zēz')
A complication of organ transplantation in children; characterized by a mononucleosislike syndrome, tonsillar enlargement, and Epstein-Barr virus seroconversion.
References in periodicals archive ?
Posttransplant lymphoproliferative disease in liver transplant patients.
Posttransplant lymphoproliferative disease in primary Epstein-Barr virus infection after liver transplantation: the role of cytomegalovirus disease.
Postoperative disease recurrence and posttransplant lymphoproliferative disease (PTLD) may be readily detected with CT.
In contrast, the penultimate chapter includes a brief summary of some successes with adoptive immunotherapy for posttransplant lymphoproliferative disease, which is generally refractory to conventional treatment.
Evaluation of use of Epstein-Barr viral load in patients after allogeneic stem cell transplantation to diagnose and monitor posttransplant lymphoproliferative disease.
One child who received intrathymic inoculation died of posttransplant lymphoproliferative disease at 6 months, and 1 control patient died of late rejection at 8 months.
Management of Posttransplant Lymphoproliferative Disease
Increased levels of circulating Epstein-Barr virus (EBV}infected lymphocytes and decreased EBV nuclear antigen antibody responses are associated with the development of posttransplant lymphoproliferative disease in solid-organ transplant recipients.
Posttransplant lymphoproliferative disease in pediatric liver transplantation: interplay between primary Epstein-Barr virus infection and immunosuppression.
Immunotherapy is an appealing therapeutic option for posttransplant lymphoproliferative disease," that deserves further study, the authors concluded.
Cytologic findings in posttransplant lymphoproliferative disease.
Increased levels of circulating Epstein--Barr virus (EBV)-infected lymphocytes and decreased EBV nuclear antigen antibody responses are associated with the development of posttransplant lymphoproliferative disease in solid-organ transplant recipients.
Full browser ?